Page 3,660«..1020..3,6593,6603,6613,662..3,6703,680..»

GM: Chemistry, manager keys to B-Mets’ run

Posted: Published on September 9th, 2014

By wbng sports GM: Chemistry, manager keys to B-Mets' run Binghamton (WBNG BINGHAMTON) When the B-Mets come home Friday for game 3 of the Eastern League Championship Series, it will mark the first time the series will be played in Binghamton since 1994. That's 20 years of B-Mets teams -- 20 years of Mets prospects coming through. What exactly is it about this year's players that's gotten them here? B-Mets general manager Jim Weed says it's a two-part answer: a good manager and team chemistry. "I've noticed the chemistry is real," Weed said Monday. "Pedro, he gets the best out of these guys day in and day out. These kids, they're all -- they all have a common goal. They want to win this thing and you can see it, it's not any one particular guy. They all play well as a team." The B-Mets begin the championship series Tuesday in Richmond. First pitch is scheduled for 6:35 p.m. See the article here: GM: Chemistry, manager keys to B-Mets' run … Continue reading

Posted in Chemistry | Comments Off on GM: Chemistry, manager keys to B-Mets’ run

A/Prof John Hill Research and Innovation Arrythmia Unit, Department of Cardiology… – Video

Posted: Published on September 9th, 2014

A/Prof John Hill Research and Innovation Arrythmia Unit, Department of Cardiology... Diamantina Health Partners Chronic Disease and Ageing Research and Innovation Networking Session A/Prof John Hill Research and Innovation Arrythmia Uni... By: Diamantina Health Partners … Continue reading

Posted in Cardiology | Comments Off on A/Prof John Hill Research and Innovation Arrythmia Unit, Department of Cardiology… – Video

Prana Biotechnology Up on Orphan Drug Status for PBT2 – Analyst Blog

Posted: Published on September 9th, 2014

Prana Biotechnology ( PRAN ) shares surged 18.7% after the company announced that the FDA has granted orphan drug designation to its Huntington disease candidate, PBT2. We note that the FDA grants orphan drug designation to candidates being developed to treat rare diseases that affect less than 200,000 people in the U.S. The status makes the candidate eligible for seven years of marketing exclusivity in the U.S. following approval. This designation also makes Prana Biotechnology eligible for certain other incentives (including tax credits for qualified clinical testing) for developing PBT2. The company plans to apply for orphan drug designation for PBT2 in other regions as well including Europe. Earlier this year, Prana Biotechnology had announced encouraging results from a phase II study evaluating the use of PBT2 in patients with Huntington disease. The company intends to submit a post phase II study dossier to the FDA and discuss the development path. Huntington disease is a neurodegenerative genetic disorder which affects more than 30,000 people in the U.S. Currently available drugs for Huntington disease include H. Lundbeck's ( HLUYY ) Xenazine, which is indicated only for involuntary movements associated with Huntington's disease. As per the company's press release, there are no … Continue reading

Posted in Biotechnology | Comments Off on Prana Biotechnology Up on Orphan Drug Status for PBT2 – Analyst Blog

Light and Life: Applications from physics to chemistry and biology – Video

Posted: Published on September 9th, 2014

Light and Life: Applications from physics to chemistry and biology Presented by Professor Siva Umapathy, Indian Institute of Science, Bangalore, India. By: National Physical Laboratory … Continue reading

Posted in Biology | Comments Off on Light and Life: Applications from physics to chemistry and biology – Video

Synthetic biology on the cusp

Posted: Published on September 9th, 2014

Whither thou goest, synthetic biology? First, lets put aside the dystopian scenarios of nasty modified viruses escaping from the fermentor Junior has jury-rigged in his bedroom lab. Designing virulent microbes is well beyond the expertise and budgets of homegrown biocoders. Moreover, its extremely difficult to improve on the lethality of nature, says Oliver Medvedik, a visiting assistant professor at The Cooper Union for the Advancement of Science and Art and the assistant director of the Maurice Kanbar Center for Biomedical Engineering. The pathogens that already exist are more legitimate cause for worry. On the other hand, its probably too much to expect kitchen counter fermenting vessels stocked with customized microorganisms exuding insulin, biodiesel, and cant-believe-it-tastes-like-butter spreadable lipids. But I can see that kind of technology scaled up to the municipal level, says Medvedik. Large fermenter arrays could provide fuels, medicines, fiber anything carbon-based. Not every city can afford or would want a petroleum refinery to supply its fuel and chemical needs. Theyre expensive and dirty. But fermenting vessels are quiet, clean, versatile, and ultimately, cheaper. Medvedik is more associated with DIYbio than such industrial-scale applications. But his work at Cooper Union and Genspace, a nonprofit organization he founded to teach … Continue reading

Posted in Biology | Comments Off on Synthetic biology on the cusp

Eastern Michigan University bioligist receives national honors

Posted: Published on September 9th, 2014

YPSILANTI -- In the nearly six years professor Anne Casper has been teaching biology at Eastern Michigan University, she has mentored 17 undergraduate students and five masters students, encouraging them as they learned to conduct scientific research. Caspers commitment to her students was recognized recently when she won an honorable mention for superior mentorship of undergraduate students in research. The Council on Undergraduate Research presented the award in the outstanding biology mentor division for young researchers. The council, founded in 1978, supports and promotes high-quality undergraduate student-faculty collaborative research and scholarship. Membership includes nearly 10,000 individuals and more than 650 colleges and universities. Only one award and two honorable mentions were awarded nationally this year in Caspers category of six or less years of experience. Caspers award was a book on mentoring undergraduate researchers. This was quite a surprise, said Casper, of Ann Arbor. Its a national award so when I applied, I put together the most competitive application I could and hoped for the best. Nomination requirements included submitting a CV (resume), a letter of support from a colleague and two letters of support from undergraduate students. Leading biologists from around the country judged the competition. Professor Casper is … Continue reading

Posted in Biology | Comments Off on Eastern Michigan University bioligist receives national honors

James Collins to receive the 2015 HFSP Nakasone Award

Posted: Published on September 9th, 2014

PUBLIC RELEASE DATE: 8-Sep-2014 Contact: Guntram Bauer gbauer@hfsp.org 33-388-215-124 Human Frontier Science Program http://www.twitter.com/hfsp The Human Frontier Science Program Organization (HFSPO) has announced that the 2015 HFSP Nakasone Award has been conferred upon James Collins of Boston University and Harvard's Wyss Institute for his innovative work on synthetic gene networks and programmable cells which launched the exciting field of synthetic biology. The HFSP Nakasone Award was established to honour scientists who have made key breakthroughs in fields at the forefront of the life sciences. It recognizes the vision of former Prime Minister Nakasone of Japan in the creation of the Human Frontier Science Program. James Collins will present the HFSP Nakasone Lecture at the 15th annual meeting of HFSP awardees to be held in La Jolla, California, in July 2015. James Collins was one of the first to show that one can engineer biological circuits out of proteins, genes and other bits of DNA. He designed and constructed a genetic toggle switch - a bistable gene circuit with broad implications for biomedicine and biotechnology. This work represents a landmark in the beginnings of synthetic biology. He showed that synthetic gene networks can be used as regulatory modules and interfaced with … Continue reading

Posted in Biology | Comments Off on James Collins to receive the 2015 HFSP Nakasone Award

ALS Ice Bucket Challenge, Virginia Bioinformatics Institute at Virginia Tech – Video

Posted: Published on September 9th, 2014

ALS Ice Bucket Challenge, Virginia Bioinformatics Institute at Virginia Tech The Virginia Bioinformatics Institute (VBI) at Virginia Tech was nominated to take the 2014 Ice Bucket Challenge for ALS by the VET-MED Master of Public Heal... By: Virginia Bioinformatics Institute at Virginia Tech … Continue reading

Posted in BioInformatics | Comments Off on ALS Ice Bucket Challenge, Virginia Bioinformatics Institute at Virginia Tech – Video

EMBL-EBI: Celebrating 20 years of bioinformatics – Video

Posted: Published on September 9th, 2014

EMBL-EBI: Celebrating 20 years of bioinformatics In 2014, the European Molecular Biology Laboratory (http://www.embl.org) turns 40 and its UK site, the European Bioinformatics Institute (http://www.ebi.ac.uk), turns 20. This film features... By: emblmedia … Continue reading

Posted in BioInformatics | Comments Off on EMBL-EBI: Celebrating 20 years of bioinformatics – Video

Convey Computer and Bluebee Partner to Strengthen Genomic Data Analysis Offering

Posted: Published on September 9th, 2014

Richardson, Texas and Delft, The Netherlands (PRWEB) September 08, 2014 Bluebee, a next generation sequencing data analysis provider, and Convey Computer Corporation, the leader in hybrid-core computing for accelerating data analytics, today announced a distribution agreement that strengthens both companies bioinformatics offerings. The partnership promotes increased innovation for bioinformatics technologies and advanced solutions for next-generation sequencing research. The distribution agreement allows Convey to resell the Bluebee Genome Analytics solution, enabling Convey to expand its offering in the bioinformatics and life sciences domain. The agreement also enables Bluebee to incorporate the existing Convey bioinformatics components into its integrated pipeline of high-performance, computer-based tools for whole-genome diagnostics. Conveys bioinformatics suite is made up of a number of personalities including the Convey GraphConstructor for de novo short read assembly, Smith-Waterman for local sequence alignment, and Burrows-Wheeler Aligner for fast reference mapping. The implementation of these algorithms on Conveys innovative hybrid-core architecture has demonstrated impressive performance gains compared to commodity clusters. Bluebee is currently extending its offering to include an accelerated BWA MEM algorithm for aligning long query reads, as well as a variant calling module on Conveys hybrid-core server architecture. These new solutions will allow geneticists to get more accurate information faster, which … Continue reading

Posted in BioInformatics | Comments Off on Convey Computer and Bluebee Partner to Strengthen Genomic Data Analysis Offering

Page 3,660«..1020..3,6593,6603,6613,662..3,6703,680..»